Compound 190
Identifiers
- Canonical SMILES:
COC(=O)[C@H]1CN(CCN1C(=O)c1ccccc1)C(=O)C(=O)c1c[nH]c2cccc(F)c12
- IUPAC name:
methyl (2S)-1-benzoyl-4-[2-(4-fluoro-1H-indol-3-yl)-2-oxoacetyl]piperazine-2-carboxylate
- InChi:
InChI=1S/C23H20FN3O5/c1-32-23(31)18-13-26(10-11-27(18)21(29)14-6-3-2-4-7-14)22(30)20(28)15-12-25-17-9-5-8-16(24)19(15)17/h2-9,12,18,25H,10-11,13H2,1H3/t18-/m1/s1
- InChiKey:
ROVDUALZLLENAS-GOSISDBHSA-N
External links
168318322 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 8.51 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 437.14 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 2.14 | |||
TPSA | 99.78 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6351 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
0.5988 | Talmapimod | DB05412 | |
0.5931 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5845 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.5706 | Gramicidin D | DB00027 | |
0.5698 | Murepavadin | DB14777 | |
0.5672 | BQ-123 | DB12054 | |
0.5672 | Somatoprim | DB12777 | |
0.5535 | Pasireotide | DB06663 | |
0.5509 | Oglufanide | DB05779 | |
0.5472 | Pruvanserin | DB13094 | |
0.5346 | LY-517717 | DB05713 | |
0.5340 | Birinapant | DB11782 | |
0.5294 | 4-Fluorotryptophane | DB03386 | |
0.5288 | Tifuvirtide | DB05413 |